Skip to main content

Advertisement

SpringerLink
Log in

Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Immunotherapies using interferons and/or interleukins are currently the treatment of choice for metastatic renal cell carcinoma (RCC). Bone metastases and non-resectable local recurrence are negative predictors for successful immunotherapy and signs of poor prognosis. The present study was designed to evaluate the effectiveness of combined immunochemotherapy (ICT) and radiation therapy (RT) for bone metastases or local recurrence from RCC in a prospective fashion. From September 1997 to September 1999, 20 patients with progressive RCC were treated with a combination of RT and ICT [s.c. interleukin-2a (IL-2), s.c. interferon alpha (IFN-α) and i.v. 5-fluorouracil]. RT started in week 2 of ICT. The radiation field was limited to the symptomatic bone metastases (15 patients) or the local recurrence (five patients). The total dosages of the RT ranged between 45 and 50 Gy, administered in fractions of from 1.8 to 2 Gy daily. In case of objective response or stable disease, the patients received up to two further ICT courses. All patients had good pain relief. Three out of 20 achieved complete remission, three had a partial remission, nine were stable and five patients had progressive disease under the combined treatment. Median survival was 21 months, mean survival 24 months (range: 5–59 months). The side effects of the combined treatment are in the same range as with ICT alone (World Health Organisation grade 2 and 3). Of 20 patients, 19 had their pain medication reduced after treatment. The combination of ICT and RT is feasible. There is remarkable pain relief. Our data suggest that the combination of immunochemotherapy and radiation therapy may induce a synergistic antitumor effect for the treatment of bone metastases or local recurrence from RCC compared to data from the literature for ICT or RT alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Atzpodien J, Kirchner H, Hänninen EL, Koerfer A, Fenner M, Menzel T, Deckert M, Franzke A, Jonas U, Poliwoda H (1993) European studies of interleukin-2 in metastatic renal cell carcinoma. Semin Oncol 20:22–26

    Google Scholar 

  2. Baloch KG, Grimer RJ, Carter SR, Tillmann RM (2000) Radical surgery for the solitary bony metastasis from renal cell carcinoma. J Bone Joint Surg 82:62–67

    Google Scholar 

  3. Barton PP, Waneck RE, Karnel FJ, Ritschl P, Kramer J, Lechner GL (1996) Embolization of bone metastases. Vasc Interv Radiol 7:81–88

    Google Scholar 

  4. Brinkmann OA, Bruns F, Prott F-J, Hertle L (1999) Possible synergy of radio therapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC). Anticancer Res 19:1583–1588

    Google Scholar 

  5. Bukowski RM (1997) Natural history and therapy of metastatic renal cell carcinoma. The role of Interleukin–2. Cancer 80:1198–1220

    Google Scholar 

  6. Capanna R, Campanacci DA (2001) The treatment of metastases in the appendicular skeleton. J Bone Joint Surg Br 83:471–481

    Google Scholar 

  7. Chatziioannou AN, Johnson ME, Pneumaticos SG, Lawrence DD, Carrasco CH (2000) Preoperative embolization of bone metastases from renal cell carcinoma. Eur Radiol 10:593–596

    Google Scholar 

  8. DeKernion JB, Belldegrun A (1992) Treatment of metastatic renal cell carcinoma. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds) Campbell’s urology. Philadelphia, W.B. Saunders, pp 1079–1084

  9. Dybal J, Haas GP, Maughan RL, Sud S, Pontes JE, Hillmann GG (1992) Synergy of radiation therapy and immunotherapy in murine renal cell carcinoma. J Urol 148:1331–1337

    Google Scholar 

  10. Elson PJ, Witte RS, Trump DL (1988) Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res. 46:7310–7313

    Google Scholar 

  11. Enneking WF, Spanier SS, Goodman MA (2003) A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop 415:4–18

    Google Scholar 

  12. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR, Munshi N, Crawford ED (2001) Nephrectomy followed by interferon alpha-2b compared with interferon alpha-2b alone for metastastic renal-cell cancer. New Engl J Med 345:1655–1659

    Google Scholar 

  13. Fossa SD, Kjolseth I, Lund G (1982) Radiotherapy of metastases from renal cancer. Eur Urol 8:340–342

    Google Scholar 

  14. Fossa SD, Lien HH, Lindegaard M (1991) Effect of recombinant interferon alfa on bone metastases of renal cell carcinoma (Letter). New Engl J. Med 324:633–634

    Google Scholar 

  15. Gleave ME, Elhilali M, Fradet Y, Davis I, Venner P, Saad F, Klotz LH, Moore ML, Paton V, Bajamonde A and the Canadian Urologic Oncology Group (1988) Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. New Engl J Med 338:1265–1271

    Google Scholar 

  16. Hanash KA, Aquilina JW, Barrett DM, Blute ML, Cockett ATK, Corica FA, Hillman GG, Zbar B, Zhuang Z (1997) Clinical research priorities in renal cell carcinoma. Cancer 80:999–1001

    Google Scholar 

  17. Harris DT (1983) Hormonal therapy and chemotherapy of renal carcinoma. Semin Oncol 10:422–430

    Google Scholar 

  18. Hofmockel G, Theiss M, Bussen D, Wirth MP, Frohmüller H (1994) Combination therapy with subcutaneously administered interleukin-2 and interferon- in advanced renal cell carcinoma. XI Congress of the European Association of Urology, Berlin, July 1994, Abstract No. 604

  19. Jacobsen KD, Folleras G, Fossa SD (1994) Metastases from renal carcinoma to the humerus or the shoulder girdle. Br J Urol 43:124–128

    Google Scholar 

  20. Kollender Y, Bickels J, Price WM, Kellar KL, Chen J, Merimsky O, Meller IC, Malawer MM (2000) Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 164:1505–1508

    Google Scholar 

  21. Mani S, Todd MB, Katz K, Poo W-J (1995) Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol 154:35–40

    Google Scholar 

  22. Metzner B, Siegmund R, Kirchner H, Atzpodien J, Illiger HJ (1991) Sprechen Knochenmetastasen auf eine Immuntherapie mit Interleukin-2 und Interferon-alpha -2b beim Nierenzellkarzinom an? Tumordiagn Ther 12:192–196

    Google Scholar 

  23. Mickisch GHJ, Garin A, Van Poppel H, De Prijck L, Sylvester R and members of the European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary group (2001) Radical nephrectomy plus interferon alfa based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358:966–970

    Google Scholar 

  24. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530–2540

    Google Scholar 

  25. Motzer RJ, Vogelzang NJ (1997) Chemotherapy for renal cell carcinoma. In: Raghavan D, Scher HI, Leibel SA, Lange P (eds) Principles and practice of genitourinary oncology. Philadelphia, Lippincott-Raven, pp 885–896

  26. Nishisaka N, Jones RF, Morse P, Kuratsukuri K, Romanowski R, Wang CY, Haas GP (2000) Inhibition of lung metastases of murine renal cell carcinoma by the combination of radiation and interferon-alpha-producing tumor cell vaccine. Cytokines Cell Mol Ther 6:199–206

    Google Scholar 

  27. Saitoh H (1981) Distant metastasis of renal adenocarcinoma. Cancer 48:1487

    Google Scholar 

  28. Smith EC, Kursh ED, Makley J, Resnick MI (1992) Treatment of osseous metastases secondary to renal cell carcinoma. J Urol 148:784–787

    Google Scholar 

  29. Swanson DA, Orovan WL, Johnson DE, Giaco G (1981) Osseous metastases of renal cell carcinoma. Urology 18: 556

    Google Scholar 

  30. Tschada R, Henkel T, Rassweiler J, Alken P (1994) Palliative Metastasenchirurgie versus konservative Therapie beim progredienten Nierenzellkarzinom. Urologe A [Suppl] 1/94, V 11.8, p.73

  31. Walther MM, Alexander RB, Weiss GH, Venzon D, Berman A, Pass HI, Linehan WM, Rosenberg SA (1993) Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma. Urology 42:250–258

    Google Scholar 

  32. Wolf JS, Aronson FR, Small EJ, Caroll PR (1994) Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens. J Surg Oncol 55:7–13

    Google Scholar 

  33. Younes E, Haas GP, Dezso B, Maughan RL, Montecillo E, Pontes JE, Hillmann GG (1995) Radiation induced effects on murine kidney tumor cells; role in the interaction of local irradiation and immunothearpy. J Urol 153:2029–2033

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University Clinic of Muenster, Albert-Schweitzer-Straße 33, 48149 Münster, Germany

    Olaf Anselm Brinkmann & Lothar Hertle

  2. Department of Radiation Oncology, University Clinic of Muenster, 48149 Münster, Germany

    Frank Bruns & Oliver Micke

  3. Department of Orthopaedic Surgery, University Clinic of Muenster, 48149 Münster, Germany

    Georg Gosheger

Authors
  1. Olaf Anselm Brinkmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank Bruns
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Georg Gosheger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliver Micke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lothar Hertle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olaf Anselm Brinkmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brinkmann, O.A., Bruns, F., Gosheger, G. et al. Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation. World J Urol 23, 185–190 (2005). https://doi.org/10.1007/s00345-004-0479-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-004-0479-8

Keywords

Search

Navigation